Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-05-31
2011-05-31
Allen, Marianne P (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S141100, C424S145100
Reexamination Certificate
active
07951368
ABSTRACT:
Compositions comprising nonpolar amino acids and specific binding agents to hepatocyte growth factor (HGF) are provided. Methods of making and using such compositions are also provided.
REFERENCES:
patent: 4847079 (1989-07-01), Kwan
patent: 4897353 (1990-01-01), Carpenter et al.
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5140010 (1992-08-01), Goldstein et al.
patent: 5272135 (1993-12-01), Takruri
patent: 5358708 (1994-10-01), Patel
patent: 5547696 (1996-08-01), Sørensen
patent: 5612315 (1997-03-01), Pikal et al.
patent: 5631225 (1997-05-01), Sørensen
patent: 5654278 (1997-08-01), Sørensen
patent: 5756468 (1998-05-01), Johnson et al.
patent: 5763409 (1998-06-01), Bayol et al.
patent: 5871736 (1999-02-01), Bruegger et al.
patent: 5874408 (1999-02-01), Nayar
patent: 5929028 (1999-07-01), Skrabanja et al.
patent: 6136294 (2000-10-01), Adjei et al.
patent: 6165467 (2000-12-01), Hagiwara et al.
patent: 6171586 (2001-01-01), Lam et al.
patent: 6270757 (2001-08-01), Warne
patent: 6447774 (2002-09-01), Metzner et al.
patent: 6458338 (2002-10-01), Adjei et al.
patent: 6525102 (2003-02-01), Chen et al.
patent: 6821515 (2004-11-01), Cleland et al.
patent: 6908610 (2005-06-01), Sato
patent: 7195670 (2007-03-01), Hansen et al.
patent: 7494650 (2009-02-01), Kim et al.
patent: 2002/0037841 (2002-03-01), Papadimitriou
patent: 2003/0092622 (2003-05-01), Sato et al.
patent: 2003/0104996 (2003-06-01), Li et al.
patent: 2003/0133928 (2003-07-01), Metzner et al.
patent: 2003/0190316 (2003-10-01), Kakuta et al.
patent: 2004/0018200 (2004-01-01), Oliver et al.
patent: 2004/0037803 (2004-02-01), Sato
patent: 2004/0224886 (2004-11-01), Chen et al.
patent: 2005/0118643 (2005-06-01), Burgess et al.
patent: 2005/0152887 (2005-07-01), Ernest
patent: 2006/0193850 (2006-08-01), Warne et al.
patent: 2007/0053871 (2007-03-01), Li et al.
patent: 0082481 (1985-03-01), None
patent: 0082481 (1990-09-01), None
patent: 1417972 (2004-05-01), None
patent: 05331071 (1993-12-01), None
patent: 07173074 (1995-07-01), None
patent: 2178309 (2002-01-01), None
patent: WO 98/22136 (1998-05-01), None
patent: WO 98/22136 (1998-08-01), None
patent: WO 01/05355 (2001-01-01), None
patent: WO 01/05355 (2001-01-01), None
patent: WO 04/000347 (2003-12-01), None
patent: WO 2004/082708 (2004-09-01), None
patent: WO 2004/082708 (2004-09-01), None
patent: WO 2004/091656 (2004-10-01), None
patent: WO 2004/091656 (2004-10-01), None
patent: WO 2004/100979 (2004-11-01), None
patent: WO 2004/100979 (2004-11-01), None
patent: WO 2005/004901 (2005-01-01), None
patent: WO 2005/009393 (2005-02-01), None
patent: WO 2005/016365 (2005-02-01), None
patent: WO 2005/009393 (2005-04-01), None
patent: WO 2005/016365 (2005-04-01), None
patent: WO 2005/044854 (2005-05-01), None
patent: WO 2005/049078 (2005-06-01), None
patent: WO 2005/058283 (2005-06-01), None
patent: WO 2005/058283 (2005-06-01), None
patent: WO 2005/058346 (2005-06-01), None
patent: WO 2005/049078 (2005-07-01), None
patent: WO 2005/063291 (2005-07-01), None
patent: WO 2005/063298 (2005-07-01), None
patent: WO 2005/044854 (2005-08-01), None
patent: WO 2005/117949 (2005-12-01), None
patent: WO 2006/112838 (2006-10-01), None
patent: WO 2007/036745 (2007-04-01), None
patent: WO 2007/036745 (2007-08-01), None
Akers et al., “Glycine Crystallization During Freezing: The Effects of Salt Form, pH, and Ionic Strength,”Pharmaceutical Research12(10): 1457-1461 (1995).
Arakawa et al., “Stabilization of Protein Structure by Sugars,”Biochemistry21: 6536-6544 (1982).
Arakawa et al., “Preferential Interactions of Proteins with Solvent Components in Aqueous Amino Acid Solutions,”Archives Biochemistry Biophysics224(1): 169-177 (1983).
Arakawa et al., “Biotechnology applications of amino acids in protein purification and formulations,”Amino Acids33: 587-605(2007).
Asquith et al., “A Study of the Ultraviolet Yellowing of Amino Acids, Peptides, and Soluble Proteins,”Textile Research J.40(3): 285-289 (1970).
Baynes et al., “Role of Arginine in the Stabilization of Proteins Against Aggregation,”Biochemistry44: 4919-4925 (2005).
Bhatnagar et al., “Study of the Individual Contributions of Ice Formation and Freeze-Concentration on Isothermal Stability of Lactate Dehydrogenase during Freezing,”J. Pharmaceutical Sciences97(2): 798-814 (2007, online).
Bush et al., “The Formulation of Recombinant Factor IX: Stability, Robustness, and Convenience,”Seminars Hematology35(2, Supp. 2): 18-21 (1998).
Carpenter et al., “The Mechanism of Cryoprotection of Proteins by Solutes,”Cryobiology25: 244-255 (1988).
Carpenter et al., “Interactions of Stabilizing Additives with Proteins During Freeze-Thawing and Freeze-Drying,”International Biological Product Freeze-Drying and Formulation, Bethesda, USA, 1990, published inDevelop. boil. Standard., 74: 225-239 (1991).
Chang et al., “Surface-Induced Denaturation of Proteins during Freezing and Its Inhibition by Surfactants,”J. Pharmaceutical Sciences85(12): 1325-1330 (1996).
Chang et al, “Mechanism of Protein Stabilization by Sugar During Freeze-Drying and Storage: Native Structure Preservation, Specific Interaction, and/or Immobilization in a Glassy Matrix?,”J. Pharmaceutical Sciences94(7): 1427-1444 (2005).
Cheung et al., “Comparative Pharmacokinetics, Safety, and Tolerability After Subcutaneous Administration of Recombinant Human Erythropoietin Formulated with Different Stabilizers,”Biopharmaceutics&Drug Disposition21: 211-219 (2000).
Fatouros et al., “Recombination factor VIII SQ—influence of oxygen, metal, ions, pH and ionic strength on its stability in aqueous solution,”International J. Pharmaceutics155: 121-131 (1997).
Franks, “Protein Destabilization at Low Temperatures,”Advances Protein Chemistry46: 105-139 (1995).
Gekko et al., “Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures,”Biochemistry20(16): 4667-4676 (1981).
Hager et al., “Investigation of Phase Behavior and Water Binding in Poly(alkylene Oxide) Solutions,”J. Applied Polymer Science25: 1559-1571 (1980).
Her et al., “Measurement of Glass Transition Temperatures of Freeze-Concentrated Solutes by Differential Scanning Calorimetry,”Pharmaceutical Research11(1): 54-59 (1994).
Her et al., “Electrolyte-Induced Changes in Glass Transition Temperatures of Freeze-Concentrated Solutes,”Pharmaceutical Research12(5): 768-772 (1995).
Huang et al., “Interaction Between Poly(ethylene glycol) and Water as Studied by Differential Scanning Calorimetry,”J. Polymer Science: Part B: Polymer Physics39:496-506 (2001).
Izutsu et al., “Decreased Protein-Stabilizing Effects of Cryoprotectants Due to Crystallization,”Pharmaceutical Research10(8): 1232-1237 (1993).
Izutsu et al., “Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying,”J. Pharmacy Pharmacology54: 1033-1039 (2002).
Lam et al., “Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2,”J. Pharmaceutical Science86(11): 1250-1255 (1997).
“Lecture 15: ‘Stealth’ particles,” from Molecular Principles of Biomaterials, Spring 2003, available online at: http://dspace.mit.edu/bitstream/handle/1721.1/36892/BE-462JSpring-2003/NR/rdonlyres/Biological-Engineering-Division/BE-462JMolecular-Principles-of-BiomaterialsSpring2003/67DAE099-B783-4AF0-8A83-CAD20EA431DE/0/BE462lect15.pdf (8 pages).
Lee et al., “The Stabilization of Proteins by Sucrose,”J. Biological Chemistry256(14): 7193-7201 (1981).
Lee et al. “Thermal Stability of Proteins in the Presence of Poly(ethylene glycols),”Biochemistry26: 7813-7819 (1987).
Li et al., “Kinetics of Glycine Crystallization during Freezing of Sucrose/Glycine Excipient Systems,”J. Pharmaceutical Sciences94(3): 625-631 (2005).
Mor
Aoki Mariko
Chu Grace C.
Huang Zhuohong
Li Tiansheng
Lueras Alexis
Allen Marianne P
Amgen Inc.
LandOfFree
Compositions of specific binding agents to hepatocyte growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of specific binding agents to hepatocyte growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of specific binding agents to hepatocyte growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2630244